BMBrenda Luana Rocha Soares Menegat

Brenda Luana Rocha Soares Menegat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Brenda Luana Rocha Soares Menegat has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association between surgeon sex and long-term postoperative outcomes: A systematic review and meta-analysis

    by Ana Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Luciana Zanchetta Pistore, Helena Casagrande Kuzli, Eduarda Eickhoff Girardi, Luiza Ramos Simionato, Valentina Schumacher, Giovana Smiderle de Antoni, Eduarda Sonda de Godoy, Laura Ferreira Conte, et al.


  • Early ileocaecal resection versus biologics therapy for localized Crohn disease: A systematic review and meta‐analysis

    by Sara Bravin, Ana L. R. S. Menegat, Brenda L. R. S. Menegat, Omar Kasimieh, Henrique Wiederkehr

    Aim: Early ileocaecal resection has recently emerged as a feasible alternative to biologics in patients with localized Crohn's disease unresponsive to standard therapy. However, early resection is not widely implemented in clinical settings, and data on its comparison to biologics therapy are limited. Methods: We searched PubMed, Scopus and Cochrane for randomized clinical trials (RCTs) and observational studies comparing early ileocaecal resection to biologics therapy in patients with localized Crohn's disease. Risk ratio (RR) was calculated for pooled outcomes; a p ‐value of < 0.05 was considered statistically significant. Results: We included 1,644 patients from one RCT and two cohort studies, where 799 patients were treated with a surgery‐first approach (48.8%). In the biologics group, patients were mainly treated with infliximab or adalimumab. Fewer patients in the resection group required additional surgery beyond the allocated treatment compared to patients treated with biologics therapy (RR 0.09; 95% CI 0.03–0.24; p = 0.01). There was no statistically significant difference between groups regarding the need to escalate treatment to the other arm's therapy. In two studies, at final follow‐up, nearly half of the resection group (315/650, 48%) were off medication without further treatment, whereas all patients treated with biologics first required ongoing medical therapy or surgery. Conclusion: In patients with localized predominantly inflammatory ileocaecal Crohn's disease, who are naïve to biologics therapy, early resection may reduce the need for subsequent treatment. These findings should be interpreted with caution due to the limited evidence base and the low to very low certainty of evidence highlighted by GRADE assessment.


  • Splenic artery embolization versus surgery for blunt splenic injuries: a systematic review, meta-analysis and trial sequential analysis stratified by hemodynamic status

    by Sara Bravin, Ana Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Alexa Moreno Mirón, Henrique Wiederkehr, Emilio Garcia Garza, Silviane Leite Melo

  • Open Access

    Effect of Prophylactic Incisional Negative Pressure Wound Therapy on Surgical Site Infection After Emergency Laparotomy: An Updated Meta‐Analysis With Trial Sequential Analysis

    by Ana Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Sara Bravin, Jacopo Lin, Henrique Wiederkehr

    Introduction: Patients undergoing emergency laparotomy are at high risk of surgical site infections (SSI), which contribute substantially to postoperative morbidity. Incisional negative pressure wound therapy (iNPWT) has been shown to reduce the incidence of SSI following elective surgery, however, its effectiveness in the emergency setting remains uncertain. Therefore, we conducted a systematic review and meta‐analysis to evaluate the effectiveness of iNPWT in reducing SSI after emergency laparotomy. Methods: We searched PubMed, Embase, and Cochrane through November 2025 for randomized controlled trials (RCTs) and observational studies comparing iNPWT to standard dressings after emergency laparotomy. Odds ratios (OR) and mean differences (MD) were pooled for relevant outcomes with 95% confidence intervals using random‐effects and inverse variance weighting. A two‐tailed p ‐value < 0.05 was considered significant. Prespecified subgroup analyses restricted to RCTs were performed. Statistical heterogeneity was assessed using the I 2 statistic. Results: Fifteen studies (6 RCTs and 9 observational) including 3369 patients were analyzed. It was found that iNPWT was associated with significantly lower odds of overall (OR 0.36; p = 0.0003), superficial, and deep SSI, with consistent findings in RCT‐only analysis (OR 0.41; p = 0.0221). iNPWT was also associated with lower odds of seroma (OR 0.57; p = 0.0325), with consistent results observed in RCT‐only analyses (OR 0.54; p = 0.025). Hospital length of stay was shorter in the iNPWT group (MD −1.49 days; p = 0.04), and iNPWT was associated with lower odds of wound dehiscence (OR 0.47; p = 0.0062), however, these findings were not confirmed in RCT‐only analyses. Postoperative complications, classified according to the Clavien–Dindo system, did not differ between groups (OR 0.93; p = 0.4973). Overall mortality was comparable between groups, although iNPWT was associated with higher follow‐up mortality. This finding was not confirmed in RCTs. Conclusion: In patients undergoing emergency laparotomy, iNPWT was associated with reduced odds of SSI and wound‐related complications compared with standard dressings. Although iNPWT was associated with higher follow‐up mortality, this finding was not confirmed in RCT‐only analyses.

  • HPV in breast cancer: prevalence and comparison with healthy tissue—a systematic review and meta-analysis

    by Pedro Henrique de Souza Wagner, Gustavo Tadeu Freitas Uchôa Matheus, Brenda Luana Rocha Soares Menegat, Ana Luíza Rocha Soares Menegat, Danilo Monteiro Ribeiro, Francisco Cezar Aquino de Moraes

    Breast cancer (BC) is the most common cancer among women worldwide, with over 2.3 million new cases annually. Recent studies suggest that Human Papillomavirus (HPV), a known oncogenic virus, may be involved in BC development. This study investigates HPV prevalence in BC samples and its potential role in tumorigenesis. Random-effects meta-analyses were conducted to estimate raw proportions and odds ratio (OR), with 95% confidence intervals (CIs). Heterogeneity was assessed using I2. Statistical significance was set at p < 0.05. Analyses were performed in R 4.5.0 RESULTS: Our meta-analysis encompassed 82 studies and evaluated 7,683 breast cancer (BC) tissue samples to assess the presence of HPV. The overall prevalence of HPV in BC specimens was estimated at 23% (95%CI: 19%-28%). When stratified by continent, Oceania exhibited the highest regional prevalence at 38%. Comparative analysis between BC tissues and healthy controls revealed a significantly increased likelihood of HPV detection in the cancer group (OR 5.06; P < 0.001). This association remained statistically robust in both case-control (OR 6.34; P < 0.001) and cross-sectional designs (OR 2.83; P < 0.001). Among continents, South America demonstrated the most pronounced association (OR 11.66; P = 0.005). Subgroup analysis based on economic classification indicated that countries with low-income settings had the highest HPV prevalence (34%; 95%CI: 9%-73%). Evaluation by BC subtype revealed that luminal B had the highest HPV-positive rate (44%; 95%CI: 27%-61%). This meta-analysis reveals a global presence of HPV in BC and suggests a possible link. Further well-designed studies are needed to confirm its role in tumorigenesis.


  • Open Access

    Preperitoneal extended totally extraperitoneal (PeTEP) repair for ventral hernia: A systematic review and meta-analysis

    by Ana Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Rafaela Duarte Vergna, Bernardo Wagner, Josélio Rodrigues de Oliveira Filho, Sergio Mazzola Poli de Figueiredo, Victor Kenzo Ivano

    Purpose: Ventral hernias are common abdominal wall defects associated with substantial healthcare burden and impaired quality of life. Minimally invasive extraperitoneal techniques have evolved to optimize midline reconstruction while avoiding intraperitoneal mesh placement, especially in the setting of diastasis recti. Preperitoneal Extended Totally Extraperitoneal (PeTEP) repair is a recently introduced approach, but evidence regarding its safety and effectiveness remains limited. Therefore, we performed a systematic review and meta-analysis to synthesize the available evidence. Methods: A systematic search of PubMed, Embase, and the Cochrane Library was conducted to identify studies evaluating PeTEP repair for ventral hernia with or without rectus diastasis. Meta-analytical pooling of outcomes was performed using a random-effects model. All statistical analyses were conducted using R software (version 4.4.1). Results: Four studies were included, comprising 99 patients, with a mean age of 51.53 years and a mean body mass index of 29.55 kg/m 2 . The pooled mean operative time was 129.48 min (95% CI 74.96 to 184.00). Hematoma occurred in 10.61% of patients (95% CI 5.14 to 20.62), and overall postoperative complications in 21.21% (95% CI 12.98 to 32.69), with no intervention required in either case. Bulging was observed in 4.88% of cases (95% CI 1.22 to 17.52). No recurrences were reported across studies, with follow-up ranging from 1 to 12 months. Conclusion: Current evidence suggests that PeTEP may be a feasible minimally invasive extraperitoneal approach for ventral hernia repair. However, further comparative studies with longer follow-up are needed.

  • Open Access

    Safety and feasibility of subtotal gastrectomy compared with completion total gastrectomy for remnant gastric cancer: A systematic review and meta-analysis

    by Brenda Luana Rocha Soares Menegat, Ana Luíza Rocha Soares Menegat, Clara Rocha Dantas, Francisco Cezar Aquino de Moraes

  • Open Access

    Endoscopic ultrasonography-guided gastroenterostomy versus conventional approaches for cancer-related malignant gastrointestinal outlet obstruction: a meta-analysis with trial sequential analysis

    by Ana Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Clara Rocha Dantas, Barbara Antonia Dups Talah, Francisco Cezar Aquino de Moraes

    Background: Malignant gastric outlet obstruction (MGOO) is a disabling complication of advanced gastrointestinal cancers, accounting for 50–80% of gastric outlet obstruction cases. As patients have unresectable disease, management is palliative and traditionally relies on surgical gastrojejunostomy (SGJ) or enteral stenting, both with limitations. Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) has recently emerged, but its role remains uncertain. We conducted a systematic review and meta-analysis comparing EUS-GE with SGJ and enteral stenting. Methods: Pubmed, Embase, Scopus, and Cochrane were searched for eligible studies. Mean differences (MDs) and risk ratio (RR) with 95% confidence intervals (CIs) were calculated using a random-effects model. Heterogeneity was examined with I 2 statistics and trial sequential analysis evaluated the cumulative evidence. Prespecified subgroup analyses were conducted for randomized controlled trials and propensity score-matched studies. Statistical analyses were performed using RStudio. Results: Twenty-two studies were included, comprising 22,211 and 1,479 patients in the EUS-GE vs SGJ and EUS-GE vs enteral stenting analysis, respectively. EUS-GE was associated with fewer infections (RR 0.46; p = 0.0137), overall postoperative complications (RR 0.38; p < 0.0001), including both major (RR 0.43; p = 0.0109) and minor complications (RR 0.35; p < 0.0001), and a reduced need for reintervention (RR 0.15; p < 0.0001) than SGJ, as well as higher clinical success (RR 1.11; p = 0.0003) compared with enteral stenting. SGJ showed higher technical success (RR 0.98; p = 0.0003). Conclusion: EUS-GE offers a safe and effective minimally invasive alternative for MGOO. Its growing evidence base supports its consideration as a preferred option in centers with appropriate expertise.


  • Neoadjuvant treatment regimens associated with pathological complete response in triple-negative breast cancer: a systematic review and network meta-analysis

    by Brenda Luana Rocha Soares Menegat, Ana Luíza Rocha Soares Menegat, Maria Victória Ferreira Piccoli, Luana Diniz Guerra Braz, Thiago Gorayeb Rebelo, Francisco Cezar Aquino de Moraes

    Triple-negative breast cancer (TNBC) lacks estrogen, progesterone, and HER2 receptors, limiting treatment options. Neoadjuvant anthracycline- and taxane-based chemotherapy remains standard, achieving pathological complete response (pCR) rates of 30%. We compared neoadjuvant treatments for early-stage TNBC using a systematic review and network meta-analysis (NMA). PubMed, EMBASE, and Cochrane were searched for randomized and observational studies of neoadjuvant treatment in TNBC. Odds ratios (OR) with 95% confidence intervals were pooled using a random-effects model. Certainty of evidence was assessed with GRADE. Statistical analyses were performed using RStudio. Thirty-seven studies with 7.683 patients were included. Twenty-five treatment nodes were formed, with paclitaxel (P) or docetaxel (D) + anthracycline - based (A) chemotherapy as the main comparator. Compared with PA-based + cyclophosphamide, higher pCR rates were observed with PA-based + carboplatin + pembrolizumab + cyclophosphamide (OR 3,04) and PA - based + carboplatin + veliparib + cyclophosphamide (OR 2,67). When DA-based + cyclophosphamide was the comparator, DA-based + cyclophosphamide + bevacizumab (OR 1,67) increased pCR. The SUCRA ranked PA-based + carboplatin + pembrolizumab, paclitaxel + carboplatin + atezolizumab, and DA-based + lobaplatin as most effective. Platinum agents, PARP inhibitors, and immune checkpoint inhibitors were associated with higher pCR rates in early-stage TNBC. CRD42025640277.

  • Neoadjuvant immune checkpoint inhibitors for muscle-invasive urothelial carcinoma: a systematic review and meta-analysis

    by Ana Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Luana Diniz Guerra Braz, Maria Victória Ferreira Piccoli, Thiago Gorayeb Rebelo, Francisco Cezar Aquino de Moraes

    1. Urothelial carcinoma (UC) is a heterogeneous group of malignancies arising from the urothelial lining of the urinary tract, with bladder cancer accounting for approximately 90% of cases, followe...